Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pfizer Inc. sell Snowman

Start price
€26.80
07.12.23 / 50%
Target price
-
07.12.24
Performance (%)
-8.92%
End price
€24.41
08.12.24
Summary
This prediction ended on 08.12.24 with a price of €24.41. With a performance of -8.92%, the SELL prediction for Pfizer Inc. by Snowman was down slightly. Dividends of €1.56 are taken into consideration when calculating the performance. Snowman has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Pfizer Inc. -1.454% -1.454% -9.604%
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

According to Snowman what are the pros and cons of Pfizer Inc. for the foreseeable future?

Pros
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Could be worthwhile Investment >10% per year
Undervalued
High dividend yield expected
Small Risks for its business
Differentiated customer and product portfolio
Known brand
Market Leader or Top 3
Cons

Comments by Snowman for this prediction

In the thread Pfizer Inc. diskutieren

Sell Pfizer Inc.

In the thread Trading Pfizer Inc.
Prediction Sell
Perf. (%) -8.92%
Target price
Change
Ends at 07.12.24

Die von Snowman gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Snowman for Pfizer Inc.

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.74
20.07.22
€55.00
20.07.23
-33.55%
21.07.23

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€41.11
09.11.21
€60.00
09.11.22
14.73%
19.01.22

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.35
15.03.21
€50.00
15.03.22
43.43%
09.11.21

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.01
18.12.20
€34.00
18.12.21
-5.35%
15.03.21

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques